Friday, August 1, 2014

Developing countries to benefit from MPP and Gilead HIV drug licensing agreement

0 comments
http://ift.tt/1qAw9cK



Upon approval for use by the US, a generic version of Gilead's HIV drug TAF will be made a...


Medicine Patent Pool (MPP), a not-for-profit organization, has partnered with pharmaceutical company Gilead Sciences to produce a generic version of a new HIV treatment drug in India and China that will be distributed in 112 countries... Continue Reading Developing countries to benefit from MPP and Gilead HIV drug licensing agreement



Section: Medical



Tags: , , ,



Related Articles:





via http://www.gizmag.com/


Post a Comment

Note: Only a member of this blog may post a comment.